Gehen Sie mit der App Player FM offline!
Relapsed/Refractory Multiple Myeloma: Role and Safety of Bispecific Antibodies
Manage episode 446396660 series 3256997
In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including:
- 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D
- The role of bispecific antibodies in R/R MM
- Safety considerations for patients while receiving a bispecific antibody
- Emerging data and clinical trials with bispecific antibodies
- Key clinical pearls for optimal use of bispecific antibodies
Presenter:
Caitlin Costello, MD
Clinical Professor of Medicine
Director, Multiple Myeloma Program
Division of Blood and Marrow Transplantation
Moores Cancer Center
UC San Diego
La Jolla, California
Link to full program:
https://bit.ly/40bjFCZ
185 Episoden
Manage episode 446396660 series 3256997
In this episode, Caitlin Costello, MD, discusses important topics related to relapsed/refractory (R/R) multiple myeloma (MM), including:
- 3 bispecific antibodies approved for the treatment of R/R MM that target BCMA or GPRC5D
- The role of bispecific antibodies in R/R MM
- Safety considerations for patients while receiving a bispecific antibody
- Emerging data and clinical trials with bispecific antibodies
- Key clinical pearls for optimal use of bispecific antibodies
Presenter:
Caitlin Costello, MD
Clinical Professor of Medicine
Director, Multiple Myeloma Program
Division of Blood and Marrow Transplantation
Moores Cancer Center
UC San Diego
La Jolla, California
Link to full program:
https://bit.ly/40bjFCZ
185 Episoden
Alle Folgen
×Willkommen auf Player FM!
Player FM scannt gerade das Web nach Podcasts mit hoher Qualität, die du genießen kannst. Es ist die beste Podcast-App und funktioniert auf Android, iPhone und im Web. Melde dich an, um Abos geräteübergreifend zu synchronisieren.